This book is the first title that focuses exclusively on kidney disease and its impact in the cardiac catheterization laboratory. The increasing prevalence of vascular risk factors such as diabetes, obesity and hypertension coupled with increased longevity has resulted in a worldwide epidemic of cardiovascular and chronic kidney disease (CKD). Never has the impact of one organ system on the other been so profound, as in the current context of cardio-renal interactions. The cross talk between the heart and kidneys is highly relevant in the field of interventional cardiology, given the…mehr
This book is the first title that focuses exclusively on kidney disease and its impact in the cardiac catheterization laboratory. The increasing prevalence of vascular risk factors such as diabetes, obesity and hypertension coupled with increased longevity has resulted in a worldwide epidemic of cardiovascular and chronic kidney disease (CKD). Never has the impact of one organ system on the other been so profound, as in the current context of cardio-renal interactions. The cross talk between the heart and kidneys is highly relevant in the field of interventional cardiology, given the increasing number of trans-catheter procedures being performed in patients with underlying kidney disease. These procedures also have a significant impact on kidney function and require thoughtful interdisciplinary planning by a cardiorenal team, to achieve optimal outcomes
This book assembles the collective expertise of several international leaders in the field of interventional cardiology and nephrology to summarize this complex interface. The book is divided into seven sections to comprehensively cover the topic, including sections on best practices with reduction of contrast associated acute kidney injury, cutting edge techniques to minimize kidney risk with complex interventions, impact of transcatheter valvular procedures on kidney function and the utility of cardio-nephrology teams . Less recognized complications with high morbidity such as athero-embolic renal disease are featured prominently, to increase awareness in the interventional cardiology and nephrology communities.
This book is a valuable resource for interventional and structural cardiologists, general cardiologists and nephrologists dealing with the significant overlap areas between these two specialties. It is also relevant to medical students, trainee physicians in nephrology and cardiology, advanced care practitioners and nursing personnel in both specialties . Given the major impact of kidney function on outcomes in patients undergoing cardiac procedures, this textbook serves as a focal point to integrate relevant clinical data from both specialties and help interventional cardiologists achieve optimal outcomes, especially in patients with (or at risk for) kidney disease.
Produktdetails
Produktdetails
Verlag: Springer / Springer International Publishing / Springer, Berlin
Artikelnr. des Verlages: 978-3-030-45416-6
1st edition 2020
Seitenzahl: 496
Erscheinungstermin: 5. August 2021
Englisch
Abmessung: 235mm x 155mm x 25mm
Gewicht: 849g
ISBN-13: 9783030454166
ISBN-10: 3030454169
Artikelnr.: 62199027
Herstellerkennzeichnung
Die Herstellerinformationen sind derzeit nicht verfügbar.
Verlag: Springer / Springer International Publishing / Springer, Berlin
Artikelnr. des Verlages: 978-3-030-45416-6
1st edition 2020
Seitenzahl: 496
Erscheinungstermin: 5. August 2021
Englisch
Abmessung: 235mm x 155mm x 25mm
Gewicht: 849g
ISBN-13: 9783030454166
ISBN-10: 3030454169
Artikelnr.: 62199027
Herstellerkennzeichnung
Die Herstellerinformationen sind derzeit nicht verfügbar.
Autorenporträt
Janani Rangaswami, MD Clinical Associate Professor Einstein Medical Center / Thomas Jefferson University Department of Medicine / Nephrology Philadelphia, PA, USA Edgar V. Lerma, MD Clinical Professor of Medicine UIC/Advocate Christ Medical Center Department of Medicine Oak Lawn, IL, USA Peter A. McCullough, MD, MPH Consultant Cardiologists and Vice Chief of Internal Medicine Baylor University Medical Center Baylor Heart and Vascular Hospital Department of Internal Medicine Texas A & M College of Medicine Division of Cardiology Dallas, TX, USA
Inhaltsangabe
Coronary artery disease in CKD: Epidemiology, Pathophysiology and Clinical Outcomes.- Noninvasive testing in the diagnosis of ischemic heart disease in CKD: Scope, Pitfalls and Future Directions.- Peripheral Arterial Disease in CKD: Disease Burden, Outcomes and Interventional Strategies.- Cardiovascular impact of Atherosclerotic Renovascular Disease.- Platelet Function testing and antiplatelet agent choice in CKD.- Choice of stents and clinical outcomes in patients with CKD.- Revascularization strategies in CKD: PCI vs CABG.- Approach to revascularization in the potential kidney transplant recipient.- Nephrology consultative approach and risk stratification prior to revascularization in CKD.- Contrast Induced AKI: Epidemiology, risk stratification and prognosis.- Contrast induced AKI: Pathophysiological Mechanisms.- Prevention of Contrast Induced AKI: Summary of volume optimization strategies.- Prevention of Contrast induced AKI: Contrast medium selection, adjuvant strategies andbest clinical practices.- Intra procedural and operator strategies for reduction of contrast induced AKI.- Effect of Percutaneous Ventricular Assist Devices on Renal Function.- Renal athero-embolic disease: An underdiagnosed entity.- Acute kidney injury with trans catheter aortic valve replacement.- Impact of kidney disease in catheter based mitral valve interventions.- Acute kidney injury with peripheral vascular interventions.- Renal Artery Stenosis: State of the Art in Diagnosis and Management.- Renal Denervation: Physiology, scope and current evidence.- Economic impact of AKI and CKD in cardiac interventions.- Biomarkers in early risk stratification and management of post catheterization AKI.- Utilization of the cardio nephrology collaborative in the era of value based medicine.
Coronary artery disease in CKD: Epidemiology, Pathophysiology and Clinical Outcomes.- Noninvasive testing in the diagnosis of ischemic heart disease in CKD: Scope, Pitfalls and Future Directions.- Peripheral Arterial Disease in CKD: Disease Burden, Outcomes and Interventional Strategies.- Cardiovascular impact of Atherosclerotic Renovascular Disease.- Platelet Function testing and antiplatelet agent choice in CKD.- Choice of stents and clinical outcomes in patients with CKD.- Revascularization strategies in CKD: PCI vs CABG.- Approach to revascularization in the potential kidney transplant recipient.- Nephrology consultative approach and risk stratification prior to revascularization in CKD.- Contrast Induced AKI: Epidemiology, risk stratification and prognosis.- Contrast induced AKI: Pathophysiological Mechanisms.- Prevention of Contrast Induced AKI: Summary of volume optimization strategies.- Prevention of Contrast induced AKI: Contrast medium selection, adjuvant strategies andbest clinical practices.- Intra procedural and operator strategies for reduction of contrast induced AKI.- Effect of Percutaneous Ventricular Assist Devices on Renal Function.- Renal athero-embolic disease: An underdiagnosed entity.- Acute kidney injury with trans catheter aortic valve replacement.- Impact of kidney disease in catheter based mitral valve interventions.- Acute kidney injury with peripheral vascular interventions.- Renal Artery Stenosis: State of the Art in Diagnosis and Management.- Renal Denervation: Physiology, scope and current evidence.- Economic impact of AKI and CKD in cardiac interventions.- Biomarkers in early risk stratification and management of post catheterization AKI.- Utilization of the cardio nephrology collaborative in the era of value based medicine.
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
USt-IdNr: DE450055826
Wir verwenden Cookies und ähnliche Techniken, um unsere Website für Sie optimal zu gestalten und Ihr Nutzererlebnis fortlaufend zu verbessern. Ihre Einwilligung durch Klicken auf „Alle Cookies akzeptieren“ können Sie jederzeit widerrufen oder anpassen. Bei „Nur notwendige Cookies“ werden die eingesetzten Techniken, mit Ausnahme derer, die für den Betrieb der Seite unerlässlich sind, nicht aktiviert. Weitere Informationen finden Sie unter „Datenschutzerklärung“.